Меню
Идёт набор NCT06664918

Effectiveness and Safety of Milk Ladders in Children with IgE-Mediated Cow's Milk Protein Allergy

Без фазы С лечением Cow Milk Allergy Food Allergy

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: oral food challenge (OFC), oral food challenge (OFC).
Кому может быть актуально
Состояния в реестре: Cow Milk Allergy, Food Allergy. Базовые параметры: 1 год — 5 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Польша
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Effectiveness and Safety of the 4-Step Versus 6-Step Milk Ladder in Children with IgE-Mediated Cow's Milk Protein Allergy: Protocol for an Open-Label Randomised Controlled Trial

Обзор

Cow's milk protein allergy (CMPA) is one of the most common food allergies in early childhood. The first-line treatment of CMPA is the elimination of cow's milk proteins (CMPs) from the child's or maternal diet. Available data from the literature indicate that most children with CMPA acquire tolerance to CMPs with age. An assessment of tolerance acquisition to CMPs is commonly performed using milk ladder. However, scientific evidence regarding the effectiveness and safety of the milk ladder in children with CMPA is limited. Currently, there is no standardised milk ladder protocol, and different versions of the ladder and recommend by scientific societies in various countries. This study aims to assess the effectiveness and safety of the 4-step milk ladder (4-ML) compared to the 6-step milk ladder (6-ML) in children with IgE-mediated CMPA. This is an open-label, randomised superiority trial with two parallel arms and a 1:1 allocation ratio.

Подробное описание

Introducing baked milk into the diet of children with cow's milk protein allergy (CMPA) has been shown to potentially accelerate the development of tolerance to raw milk. However, there is no standardised milk ladder protocol, and different scientific societies across countries recommend varying versions.

This study aims to assess the effectiveness and safety of the 4-step milk ladder (4-ML) compared to the 6-step milk ladder (6-ML) in children with IgE-mediated CMPA.

We will perform an open-label randomised trial with two parallel arms in two departments of the same academic hospital. A total of 92 children with IgE-mediated CMPA will be allocated to introduce cow's milk into their diet according to either 4-ML or 6-ML with a 4-week break period between subsequent steps. Oral food challenge (OFCs) with tested products at each subsequent step of the milk ladder will be conducted in hospital settings. The primary outcome will be the percentage of children with tolerance to non-heated cow's milk proteins defined as no allergic reaction to non-heated cow's milk (120-240 ml depending on the age of the patient) during the last OFC; measured at the end of the 12-week observation period for the 4-ML and 20-week observation period for the 6-ML. Secondary outcomes will include the percentage of children with a negative OFC to each milk ladder step; the percentage of children with anaphylaxis (both those who were treated and who were not treated with adrenaline); the percentage of children with exacerbation of atopic dermatitis; growth; compliance; and quality of life of the caregivers and parents' anxiety about adverse events during their child's OFC.

The statistical analyses will be conducted with StatsDirect. The Mann-Whitney U test will be used to compare the means of continuous variables if non-normal distribution will be assessed. Proportions will be compared with the Fisher exact test. The difference in study groups was considered significant when the P value will be \<05. The results of this study will be analyzed on the basis of intention to treat.

Вмешательства

  • Другое oral food challenge (OFC)
    oral food challenges with subsequent steps of 4-step milk ladder (muffin, pancake,baked hard cheese, yoghurt/pasteurised cow milk or modified cow milk)
  • Другое oral food challenge (OFC)
    oral food challenges with subsequent steps of 6-step milk ladder (cookie, muffin, pancake,baked hard cheese, yoghurt, pasteurised cow milk or modified cow milk)

Первичные конечные точки

  • The percentage of children who acquired tolerance to non-heated cow's milk proteins [Срок оценки: at the end of the observation period (12 or 20 weeks, depending on the study arm)]
Вторичные конечные точки (10)
  • Percentage of children who experienced anaphylaxis [Срок оценки: during the observation period (12 or 20 weeks, depending on the study arm)]
  • Percentage of children who required adrenaline administration [Срок оценки: during the observation period (12 or 20 weeks, depending on the study arm)]
  • Change in BMI-for-age z-score [Срок оценки: at the end of the observation period (12 or 20 weeks, depending on the study arm) compared to baseline (before the first OFC)]
  • Assessment of parents' anxiety about adverse events during their child's OFC [Срок оценки: before each OFC, which means before the first OFC and depending on the study arm: after 4,8,12 weeks or after 4,8,12,16,20 weeks]
  • In a subgroup of children with atopic dermatitis, the percentage of children with mild, moderate, and severe atopic dermatitis [Срок оценки: before and after each OFC (during the examination following each observation period) which means before and after the first OFC and and before and after subsequent OFCs depending on the study arm: after 4,8,12 weeks or after 4,8,12,16,20 weeks]
  • Percentage of children with full compliance to the intervention protocol [Срок оценки: at the end of the observation period (12 or 20 weeks, depending on the study arm)]
  • Percentage of children with negative OFCs to each cow's milk form after receiving the full planned amount for each OFC [Срок оценки: at the end of the observation period (12 or 20 weeks, depending on the study arm)]
  • Percentage of children with negative OFCs to each cow's milk form after receiving any tolerated dose [Срок оценки: after the end of the observation period (12 or 20 weeks, depending on the study arm)]
  • Change in total score of The Food Allergy Questionnaire of Life - Parent Form (FAQLQ-PF) [Срок оценки: at the end of the observation period (12 or 20 weeks, depending on the study arm) compared to baseline (before the first OFC)]
  • Change in length/height-for-age z-score [Срок оценки: at the end of the observation period (12 or 20 weeks, depending on the study arm) compared to baseline (before the first OFC)]

Критерии участия

Критерии включения

  • Age between 1 and 5 years.
  • Diagnosis of IgE-mediated CMPA confirmed according to ESPGHAN guidelines, by a positive OFC with CMPs. In high-risk children (i.e., with a history of anaphylaxis), diagnosis based on positive skin prick testing and/or elevated specific IgE to CMPs is sufficient.
  • On a therapeutic elimination diet for at least 6 months or up to 12 months of age.12
  • Eligible regardless of the risk of systemic reaction (anaphylaxis) and asthma.
  • Good overall health status.
  • Parents without language barriers.
  • Written informed consent signed by parents.
  • Good cooperation with the child's guardians.

Критерии исключения

  • Uncontrolled asthma, defined as the presence of shortness of breath, chest tightness, cough, and/or auscultatory changes despite treatment.
  • Signs of exacerbation of a chronic disease.
  • Signs of acute infectious disease (i.e., acute runny nose, cough, subfebrile fever, or fever).
  • Signs of exacerbation of another allergic disease (i.e., conjunctivitis, allergic rhinitis, atopic dermatitis).
  • Anaphylaxis due to CMPs in the last 6 months.
  • Used antihistamines within 3-10 days before the challenge (depending on the characteristics of the drug and the reason for use).
  • Acquired tolerance to baked CMPs or higher steps of the milk ladder.
  • Use of immunosuppressive drugs or immunotherapy

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Лечение

Центры проведения

Польша · 2 центра
  • Medical University od Warsaw, Department od Pediatrics — Warsaw
  • Medical University od Warsaw — Warsaw

Публикации

  • Wiszniewska D, Horvath A, Strozyk A, Nowak-Wegrzyn A, Grzela K, Szajewska H. Effectiveness and safety of the four-step versus six-step milk ladder in children with IgE-mediated cow's milk protein allergy: protocol for an open-label randomised controlled trial. BMJ Open. 2025 Apr 14;15(4):e098314. doi: 10.1136/bmjopen-2024-098314. PMID 40228856

Идентификаторы

NCT: NCT06664918 · ML2024

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗